Skip to main content
. 2021 Dec 28;114(4):565–570. doi: 10.1093/jnci/djab231

Figure 2.

Figure 2.

Risk prediction for clonal hematopoiesis (CH)–associated gene mutations based on binomial logistic regression dependent on age at blood draw (age), number of prior platinum-based chemotherapy lines (PtLines), and BRCA1/2 germline mutation status (gBRCA1/2). Coefficients (β), standard errors (SE), odds ratios (OR), 95% confidence intervals (CI), and P values (P, 2-sided Wald test) as obtained from fitting a binomial logistic regression model for the observation of CH–associated gene mutations in ASXL1 (A), DNMT3A (B), TET2 (C), PPM1D (D), and TP53 (E).